Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 279

1.

Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study.

De Toni EN, Schlesinger-Raab A, Fuchs M, Schepp W, Ehmer U, Geisler F, Ricke J, Paprottka P, Friess H, Werner J, Gerbes AL, Mayerle J, Engel J.

Gut. 2019 Mar 16. pii: gutjnl-2018-318193. doi: 10.1136/gutjnl-2018-318193. [Epub ahead of print]

2.

Efficacy and safety of CT-guided high-dose-rate interstitial brachytherapy in primary and secondary malignancies of the pancreas.

Omari J, Heinze C, Wilck A, Hass P, Seidensticker M, Seidensticker R, Mohnike K, Ricke J, Pech M, Powerski M.

Eur J Radiol. 2019 Mar;112:22-27. doi: 10.1016/j.ejrad.2018.12.020. Epub 2018 Dec 28.

PMID:
30777214
3.

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, Nault JC, Neumann U, Ricke J, Sangro B, Schirmacher P, Verslype C, Zech CJ, Arnold D, Martinelli E.

Ann Oncol. 2019 Jan 31. doi: 10.1093/annonc/mdy510. [Epub ahead of print] No abstract available.

PMID:
30715202
4.

Needle track seeding in hepatocellular carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 588 catheter placements.

Damm R, Zörkler I, Rogits B, Hass P, Omari J, Powerski M, Kropf S, Mohnike K, Pech M, Ricke J, Seidensticker M.

J Contemp Brachytherapy. 2018 Dec;10(6):516-521. doi: 10.5114/jcb.2018.80626. Epub 2018 Dec 28.

5.

Wavelet-based reconstruction of dynamic susceptibility MR-perfusion: a new method to visualize hypervascular brain tumors.

Huber T, Rotkopf L, Wiestler B, Kunz WG, Bette S, Gempt J, Preibisch C, Ricke J, Zimmer C, Kirschke JS, Sommer WH, Thierfelder KM.

Eur Radiol. 2019 May;29(5):2669-2676. doi: 10.1007/s00330-018-5892-2. Epub 2018 Dec 14.

PMID:
30552476
6.

Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial.

Mohnike K, Steffen IG, Seidensticker M, Hass P, Damm R, Peters N, Seidensticker R, Schütte K, Arend J, Bornschein J, Streitparth T, Wybranski C, Wieners G, Stübs P, Malfertheiner P, Pech M, Ricke J.

Cardiovasc Intervent Radiol. 2019 Feb;42(2):239-249. doi: 10.1007/s00270-018-2127-5. Epub 2018 Nov 28.

PMID:
30488303
7.

Image-guided interstitial high-dose-rate brachytherapy in the treatment of metastatic esophageal squamous cell carcinoma.

Omari J, Heinze C, Wilck A, Hass P, Seidensticker M, Damm R, Fischbach K, Ricke J, Pech M, Powerski M.

J Contemp Brachytherapy. 2018 Oct;10(5):439-445. doi: 10.5114/jcb.2018.79230. Epub 2018 Oct 23.

8.

Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors : A systematic analysis of 102 cases.

Powerski M, Penzlin S, Hass P, Seidensticker R, Mohnike K, Damm R, Steffen I, Pech M, Gademann G, Ricke J, Seidensticker M.

Strahlenther Onkol. 2019 Mar;195(3):265-273. doi: 10.1007/s00066-018-1404-1. Epub 2018 Nov 23.

PMID:
30470846
9.

Treatment of metastatic, imatinib refractory, gastrointestinal stroma tumor with image-guided high-dose-rate interstitial brachytherapy.

Omari J, Drewes R, Matthias M, Mohnike K, Seidensticker M, Seidensticker R, Streitparth T, Ricke J, Powerski M, Pech M.

Brachytherapy. 2019 Jan - Feb;18(1):63-70. doi: 10.1016/j.brachy.2018.09.006. Epub 2018 Oct 29.

PMID:
30385116
10.

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Vogel A, Cervantes A, Chau I, Daniele B, Llovet J, Meyer T, Nault JC, Neumann U, Ricke J, Sangro B, Schirmacher P, Verslype C, Zech CJ, Arnold D, Martinelli E; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv238-iv255. doi: 10.1093/annonc/mdy308. No abstract available.

PMID:
30285213
11.

Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma.

Kazmierczak PM, Burton NC, Keinrath G, Hirner-Eppeneder H, Schneider MJ, Eschbach RS, Heimer M, Solyanik O, Todica A, Reiser MF, Ricke J, Cyran CC.

PLoS One. 2018 Oct 3;13(10):e0204930. doi: 10.1371/journal.pone.0204930. eCollection 2018.

12.

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT.

Kunz WG, Eschbach RS, Stahl R, Kazmierczak PM, Bartenstein P, Rominger A, Auernhammer CJ, Spitzweg C, Ricke J, Cyran CC.

Cancer Imaging. 2018 Sep 20;18(1):34. doi: 10.1186/s40644-018-0168-2.

13.

Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage.

Cappelli A, Sangro P, Mosconi C, Deppe I, Terzi E, Bilbao JI, Rodriguez-Fraile M, De Benedittis C, Ricke J, Golfieri R, Sangro B.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):661-668. doi: 10.1007/s00259-018-4152-7. Epub 2018 Sep 12.

PMID:
30209522
14.

Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival.

Seidensticker R, Damm R, Enge J, Seidensticker M, Mohnike K, Pech M, Hass P, Amthauer H, Ricke J.

BMC Cancer. 2018 Sep 10;18(1):882. doi: 10.1186/s12885-018-4784-9.

15.

Image-guided Interstitial Brachytherapy in the Management of Metastasized Anal Squamous Cell Carcinoma.

Heinze C, Omari J, Othmer M, Hass P, Seidensticker M, Damm R, Ricke J, Pech M, Powerski MJ.

Anticancer Res. 2018 Sep;38(9):5401-5407. doi: 10.21873/anticanres.12870.

PMID:
30194195
16.

Image Quality Assessment for Low-Dose-CT in Hybrid SPECT/CT Imaging.

Grosser OS, Ruf J, Kupitz D, Czuczwara D, Loewenthal D, Thormann M, Furth C, Ricke J, Pech M, Kreissl MC, Amthauer H.

Nuklearmedizin. 2018 Aug;57(4):153-159. doi: 10.3413/Nukmed-0953-17-12. Epub 2018 Aug 20.

PMID:
30125927
17.

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies.

Gibbs P, Heinemann V, Sharma NK, Taieb J, Ricke J, Peeters M, Findlay M, Robinson B, Jackson C, Strickland A, Gebski V, Van Buskirk M, Zhao H, van Hazel G; SIRFLOX and FOXFIRE Global Trial Investigators.

Clin Colorectal Cancer. 2018 Dec;17(4):e617-e629. doi: 10.1016/j.clcc.2018.06.001. Epub 2018 Jun 12.

PMID:
30033117
18.

CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial.

Froelich MF, Heinemann V, Sommer WH, Holch JW, Schoeppe F, Hesse N, Baumann AB, Kunz WG, Reiser MF, Ricke J, D'Anastasi M, Stintzing S, Modest DP, Kazmierczak PM, Hofmann FO.

Eur Radiol. 2018 Dec;28(12):5284-5292. doi: 10.1007/s00330-018-5454-7. Epub 2018 Jun 7.

PMID:
29882070
19.

What Is New in Prostate Artery Embolization for Lower Urinary Tract Symptoms?

McClure TD, Ricke J.

Eur Urol Focus. 2018 Jan;4(1):46-48. doi: 10.1016/j.euf.2018.04.022. Epub 2018 May 28. Review.

PMID:
29853426
20.

Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases.

Winter KS, Hofmann FO, Thierfelder KM, Holch JW, Hesse N, Baumann AB, Modest DP, Stintzing S, Heinemann V, Ricke J, Sommer WH, D'Anastasi M.

Eur Radiol. 2018 Nov;28(11):4839-4848. doi: 10.1007/s00330-018-5424-0. Epub 2018 May 7.

PMID:
29736851

Supplemental Content

Loading ...
Support Center